Concerta (Methylphenidate) 36mg

  Concerta (Methylphenidate) 36mg The suggested dosage for each extended-release tablet is one oral dose per day for 12 hours of action. Each tablet contains 18, 27, 36, or 54 milligrams of methylphenidate HCl USP. Methyl α-phenyl-2-piperidineacetate hydrochloride, also known as d,l (racemic) methylphenidate HCl, is its chemical formula. The empirical formula for it is C14H19NO2•HCl. Methylphenidate HCl USP has the following structural formula and is a white, odorless crystalline powder. A couple of its remedies are acid and litmus. It dissolves relatively little in acetone and chloroform but readily in methanol, water, and alcohol. Its molecular weight is 269.77.

CONCERTA® is a central nervous system (CNS) stimulant. There are four strengths available for CONCERTA® pills. For each extended-release tablet, the recommended dosage is one oral dose per day for a 12-hour duration of action. Each tablet contains 18 mg, 27 mg, 36 mg, or 54 mg of methylphenidate HCl USP. Methyl α-phenyl-2-piperidineacetate hydrochloride has the chemical formula d,l (racemic) methylphenidate HCl. The empirical formula for it is C14H19NO2•HCl. Methylphenidate HCl USP is a crystalline powder with a white, odorless structural composition. Acid and litmus are two of its treatment methods. It dissolves readily in methanol, water, and alcohol, but only very slightly in acetone and chloroform. It contains 269,77 atoms.

CONCERTA® also contains carnauba wax, cellulose acetate, hypromellose, lactose, phosphoric acid, poloxamer, propylene glycol, sodium chloride, povidone, stearic acid, succinic acid, titanium dioxide, and triacetin, in addition to BHT.

Concerta (Methylphenidate) 36mg

The device, which looks like a regular tablet, comprises an immediate-release drug coating and a semipermeable membrane that encircles an osmotically active trilayer core.The trilayer core is made up of a push layer with osmotically active ingredients and two drug layers that hold the medicine and excipients. The tablet’s drug-layer end has a precisely laser-drilled opening. The medication coating dissolves in an hour in a watery environment, like the gastrointestinal tract, and delivers a starting dose of methylphenidate. Water seeps into the tablet core through the membrane. By expanding the osmotically active polymer excipients, the aperture allows methylphenidate to be released. Drug distribution is regulated by the membrane, which also governs the pace at which water enters the tablet core.

Additionally, the drug-concentration gradient built into the two drug layers of CONCERTA® causes the drug release rate from the system to increase throughout 6 to 7 hours. Together with the insoluble core components of the tablet, the biologically inert components of the tablet stay whole during gastrointestinal transit and are expelled in the stool as a tablet shell. It is possible that, in some instances, mainly when digital enhancing techniques are applied, CONCERTA® extended-release tablets will appear on abdominal X-rays.